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background:  HDL cholesterol is known to have vascular protective effect. However, the relationship between HDL level and coronary 
plaque characteristics has never been studies. Moreover, vascular response to statin therapy in subjects with high vs. low HDL has not 
been compared.
Methods:  From a randomized trial (NCT01023607), we identified 97 lipid-rich plaques from 69 patients who were randomized to receive 
atorvastatin 60mg, rosuvastatin 10mg or atorvastatin 20mg. Serial OCT and IVUS imaging were performed at baseline, 6-month, and 
12-month. We divided patients into low HDL group and high HDL group by the median of HDL value at baseline. The fibrous cap thickness 
(FCT), mean lipid arc by OCT and the percent atheroma volume (PAV) on IVUS were compared between the groups.
Results:  The median HDL value was 40.2 mg/dl in the low HDL group and 56.2 mg/dl in the high HDL group. The clinical characteristics 
were similar between the low HDL group and the high HDL group except for the prevalence of male (74.3% vs. 50.0%, P=0.04), 
hypertension (48.6% vs. 79.4%, P<0.01) and diabetes (37.1% vs. 23.5%, P=0.04). The FCT, mean lipid arc and PAV were similar between 
the two groups. At 12-month, vascular responses to lipid lowering therapy were also comparable between the two groups (Table).
conclusion:  Coronary plaque characteristics were similar between patients with low HDL vs. high HDL. Vascular response to lipid 
lowering therapy was also similar between these two groups.
 
